000 02709cam a2200397 4500500
005 20250112070530.0
041 _afre
042 _adc
100 1 0 _aBisulli, Francesca
_eauthor
700 1 0 _a Licchetta, Laura
_eauthor
700 1 0 _a Baldassari, Sara
_eauthor
700 1 0 _a Muccioli, Lorenzo
_eauthor
700 1 0 _a Marconi, Caterina
_eauthor
700 1 0 _a Cantalupo, Gaetano
_eauthor
700 1 0 _a Myers, Candace
_eauthor
700 1 0 _a Menghi, Veronica
_eauthor
700 1 0 _a Minardi, Raffaella
_eauthor
700 1 0 _a Caporali, Leonardo
_eauthor
700 1 0 _a Marini, Carla
_eauthor
700 1 0 _a Guerrini, Renzo
_eauthor
700 1 0 _a Mefford, Heather C.
_eauthor
700 1 0 _a Tinuper, Paolo
_eauthor
700 1 0 _a Pippucci, Tommaso
_eauthor
245 0 0 _aSCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus
260 _c2019.
500 _a21
520 _aAimsEpilepsy with auditory features (EAF) is a focal epilepsy syndrome characterized by prominent auditory ictal manifestations. Two main genes, LGI1 and RELN, have been implicated in EAF, but the genetic aetiology remains unknown in half of families and most sporadic cases. We previously described a pathogenic SCN1A missense variant (p.Thr956Met) segregating in a large family in which the proband and her affected daughter had EAF, thus satisfying the minimum requirement for diagnosis of autosomal dominant EAF (ADEAF). However, the remaining eight affected family members had clinical manifestations typically found in families with genetic epilepsy with febrile seizures plus (GEFS+). We aimed to investigate the role/impact of SCN1A mutations in EAF.MethodsWe detailed the phenotype of this family and report on SCN1A screening in a cohort of 29 familial and 52 sporadic LGI1 variant-negative EAF patients.ResultsWe identified two possibly pathogenic missense variants (p.Tyr790Phe and p.Thr140Ile) in sporadic patients (3.8%) showing typical EAF and no antecedent febrile seizures. Both p.Thr956Met and p.Tyr790Phe were previously described in unrelated patients with epilepsies within the GEFS+ spectrum.ConclusionSCN1A mutations may be involved in EAF within the GEFS+ spectrum, however, the role of SCN1A in EAF without features that lead to a suspicion of underlying GEFS+ remains unclear and should be elucidated in future studies.
690 _aplus
690 _alateral temporal epilepsy
690 _aADLTE
690 _agenetics
690 _aGEFS
690 _aADEAF
786 0 _nEpileptic Disorders | Vol 21 | 2 | 2019-02-01 | p. 185-191 | 1294-9361
856 4 1 _uhttps://shs.cairn.info/revue-epileptic-disorders-2019-2-page-185?lang=en
999 _c246278
_d246278